Chicken IL-17 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy
Poultry Science · 2025
DOI: 10.1016/j.psj.2025.105247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Poultry Science, 2025. Verfasst von Jianlou Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Hebei Agricultural University, Hebei Veterinary Biotechnology Innovation Center, Baoding 071001, China. Hauptthemen laut MEDLINE: Chickens, Infectious bursal disease virus, Birnaviridae Infections, Poultry Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Hebei Province Medical Science Research Key Project.
Abstract (Originalsprache)
Infectious bursal disease virus (IBDV) is an important immunosuppressive virus in chickens, which caused an acute and highly contagious infectious disease and resulted in considerable economic losses in the world poultry industry. Although IBDV VP2 DNA vaccine has been extensively proved only partial protection, the efficacy of DNA vaccines against IBDV can be augmented by choosing potential molecular adjuvants. To investigate whether chicken IL-17 (chIL-17) is qualified for the molecular adjuvant, we constructed chIL-17 gene vector, co-immunized chickens with chIL-17 gene vector and IBDV VP2 DNA vector, and analyzed the effect of IL-17 gene on the immunogenicity of VP2 DNA vaccine. Results showed that co-administrated chIL-17 gene and VP2 DNA vaccine significantly increased IBDV-specific serum antibody titer, and promoted lymphocyte proliferation and interference-γ (IFN-γ) production. Mechanically, chIL-17 reduced virus titer in bursa of fabricius tissue and mortality of IBDV-infected chicken. More importantly, chIL-17 gene significantly enhanced the protection induced by the VP2 gene against virulent IBDV infection.These data show that chIL-17 is a promising immunoadjuvant to facilitate humoral as well as cellular immunity in a vaccine setting against IBDV, and suggest that it should be evaluated as a new DNA vaccine adjuvant in strategies for other poultry diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Hebei Agricultural University, Hebei Veterinary Biotechnology Innovation Center, Baoding 071001, China.
- School of Basic Medical Sciences, Hebei University, Baoding 071001, China.
- College of Life Sciences, Hebei Agricultural University, Baoding 071001, China.
- Department of Agriculture and Husbandry, Handan Vocational College of Science and Technology, Handan 056046, China.
- Department of Agriculture and Husbandry, Handan Vocational College of Science and Technology, Handan 056046, China. Electronic address: hdwly123@163.com.
Förderung
- Natural Science Foundation of Hebei Province
- Hebei Province Medical Science Research Key Project
Zitieren
APA
Zhang, J., Li, W., Huo, S., Xin, X., & Wang, L. (2025). Chicken IL-17 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy. Poultry Science. https://doi.org/10.1016/j.psj.2025.105247
Vancouver
Zhang J, Li W, Huo S, Xin X, Wang L. Chicken IL-17 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy. Poultry Science. 2025. doi:10.1016/j.psj.2025.105247
BibTeX
@article{Zhang2025,
author = {Zhang, Jianlou and Li, Wenyan and Huo, Shanshan and Xin, Xiaojing and Wang, Liyue},
title = {Chicken IL-17 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy},
journal = {Poultry Science},
year = {2025},
doi = {10.1016/j.psj.2025.105247}
}
EUVIMED